Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Laureate Education | LAUR | Feb 28, 2025 | 19.94 | +0.40 |
LAVA Therapeutics | LVTX | Feb 28, 2025 | 1.29 | 0.00 |
Lavoro | LVRO | Feb 28, 2025 | 4.79 | -3.04 |
Lazard A | LAZ | Feb 28, 2025 | 50.15 | +3.19 |
Lazard Global Total Return and Income Fund | LGI | Feb 28, 2025 | 16.40 | -0.12 |
Lazydays | GORV | Feb 28, 2025 | 0.51 | -15.69 |
LCI Industries | LCII | Feb 28, 2025 | 103.82 | +1.13 |
LCNB | LCNB | Feb 28, 2025 | 15.49 | +3.89 |
Lead Real Estate ADR | LRE | Feb 28, 2025 | 1.32 | +7.93 |
Leap Therapeutics | LPTX | Feb 28, 2025 | 0.46 | -0.04 |
Lear | LEA | Feb 28, 2025 | 93.99 | -2.43 |
LeddarTech | LDTC | Feb 28, 2025 | 0.53 | -4.95 |
Lee Enterprises | LEE | Feb 28, 2025 | 9.70 | +6.01 |
Legacy Housing | LEGH | Feb 28, 2025 | 24.69 | +1.19 |
LegalZoom.com | LZ | Feb 28, 2025 | 10.16 | +1.40 |
Legato Merger III | LEGT | Feb 28, 2025 | 10.39 | 0.00 |
Legend Biotech ADR | LEGN | Feb 28, 2025 | 35.01 | -4.66 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Feb 28, 2025 | 40.88 | +1.09 |
Leggett & Platt | LEG | Feb 28, 2025 | 9.17 | +0.33 |
Leidos | LDOS | Feb 28, 2025 | 129.97 | +0.23 |
Leishen Energy Holding Co | LSE | Feb 28, 2025 | 5.60 | 0.00 |
LeMaitre Vascular | LMAT | Feb 28, 2025 | 91.85 | -8.07 |
Lemonade | LMND | Feb 28, 2025 | 36.35 | +2.51 |
LendingClub | LC | Feb 28, 2025 | 12.79 | +2.08 |
LendingTree | TREE | Feb 28, 2025 | 40.39 | +3.88 |
Lendway | LDWY | Feb 28, 2025 | 3.95 | +1.80 |
Lennar A | LEN | Feb 28, 2025 | 119.63 | -0.61 |
Lennar B | LEN-B | Feb 28, 2025 | 115.70 | +0.06 |
Lennox International | LII | Feb 28, 2025 | 601.05 | -0.20 |
LENSAR | LNSR | Feb 28, 2025 | 13.00 | +19.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.